智飞生物公告2025年上半年营业收入49.19亿元同比下降73.06%。净利润亏损5.97亿元上年同期净利润为22.34

智通财经
Aug 18
智飞生物公告2025年上半年营业收入49.19亿元同比下降73.06%。净利润亏损5.97亿元上年同期净利润为22.34亿元。报告期内受民众接种意愿下降、市场需求变化等多重因素影响公司与默沙东协商一致调整了本年度HPV疫苗的采购与供应节奏并持续开展需求评估以共同应对市场变化。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10